237 related articles for article (PubMed ID: 25522403)
1. Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging.
Baldinger P; Höflich AS; Mitterhauser M; Hahn A; Rami-Mark C; Spies M; Wadsak W; Lanzenberger R; Kasper S
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522403
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep--A randomized, placebo-controlled trial.
Kasper S; Anghelescu I; Dienel A
Eur Neuropsychopharmacol; 2015 Nov; 25(11):1960-7. PubMed ID: 26293583
[TBL] [Abstract][Full Text] [Related]
3. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial.
Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Dienel A; Schläfke S
Int Clin Psychopharmacol; 2010 Sep; 25(5):277-87. PubMed ID: 20512042
[TBL] [Abstract][Full Text] [Related]
4. In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder.
Zanderigo F; Pantazatos S; Rubin-Falcone H; Ogden RT; Chhetry BT; Sullivan G; Oquendo M; Miller JM; Mann JJ
Brain Struct Funct; 2018 Jul; 223(6):2609-2625. PubMed ID: 29550938
[TBL] [Abstract][Full Text] [Related]
5. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
Woelk H; Schläfke S
Phytomedicine; 2010 Feb; 17(2):94-9. PubMed ID: 19962288
[TBL] [Abstract][Full Text] [Related]
6. No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial.
Seifritz E; Möller HJ; Volz HP; Müller WE; Hopyan T; Wacker A; Schläfke S; Kasper S
Int J Neuropsychopharmacol; 2021 Mar; 24(3):171-180. PubMed ID: 33300578
[TBL] [Abstract][Full Text] [Related]
7. An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review.
Kasper S
Int J Psychiatry Clin Pract; 2013 Nov; 17 Suppl 1():15-22. PubMed ID: 23808618
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of Silexan on sleep are mediated by its anxiolytic effect.
Seifritz E; Schläfke S; Holsboer-Trachsler E
J Psychiatr Res; 2019 Aug; 115():69-74. PubMed ID: 31121394
[TBL] [Abstract][Full Text] [Related]
9. Silexan, an essential oil from flowers of Lavandula angustifolia, is not recognized as benzodiazepine-like in rats trained to discriminate a diazepam cue.
Silenieks LB; Koch E; Higgins GA
Phytomedicine; 2013 Jan; 20(2):172-7. PubMed ID: 23207249
[TBL] [Abstract][Full Text] [Related]
10. Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine.
Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Schläfke S; Dienel A
Int J Neuropsychopharmacol; 2014 Jun; 17(6):859-69. PubMed ID: 24456909
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological basis of the anxiolytic and antidepressant properties of Silexan®, an essential oil from the flowers of lavender.
Müller WE; Sillani G; Schuwald A; Friedland K
Neurochem Int; 2021 Feb; 143():104899. PubMed ID: 33181239
[TBL] [Abstract][Full Text] [Related]
12. Light-dependent alteration of serotonin-1A receptor binding in cortical and subcortical limbic regions in the human brain.
Spindelegger C; Stein P; Wadsak W; Fink M; Mitterhauser M; Moser U; Savli M; Mien LK; Akimova E; Hahn A; Willeit M; Kletter K; Kasper S; Lanzenberger R
World J Biol Psychiatry; 2012 Sep; 13(6):413-22. PubMed ID: 22111663
[TBL] [Abstract][Full Text] [Related]
13. Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region.
Hirvonen J; Kajander J; Allonen T; Oikonen V; Någren K; Hietala J
J Cereb Blood Flow Metab; 2007 Jan; 27(1):185-95. PubMed ID: 16685258
[TBL] [Abstract][Full Text] [Related]
14. Serotonergic neurotransmission in the living human brain: a positron emission tomography study using [¹¹C]dasb and [¹¹C]WAY100635 in young healthy men.
Takano H; Ito H; Takahashi H; Arakawa R; Okumura M; Kodaka F; Otsuka T; Kato M; Suhara T
Synapse; 2011 Jul; 65(7):624-33. PubMed ID: 21484882
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials.
Möller HJ; Volz HP; Dienel A; Schläfke S; Kasper S
Eur Arch Psychiatry Clin Neurosci; 2019 Mar; 269(2):183-193. PubMed ID: 29150713
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials.
Dold M; Bartova L; Volz HP; Seifritz E; Möller HJ; Schläfke S; Kasper S
Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1615-1628. PubMed ID: 36717399
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Silexan in mixed anxiety-depression--A randomized, placebo-controlled trial.
Kasper S; Volz HP; Dienel A; Schläfke S
Eur Neuropsychopharmacol; 2016 Feb; 26(2):331-340. PubMed ID: 26718792
[TBL] [Abstract][Full Text] [Related]
18. Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-¹¹C]WAY-100635.
Kranz GS; Rami-Mark C; Kaufmann U; Baldinger P; Hahn A; Höflich A; Savli M; Stein P; Wadsak W; Mitterhauser M; Winkler D; Lanzenberger R; Kasper S
Psychoneuroendocrinology; 2014 Jul; 45():1-10. PubMed ID: 24845171
[TBL] [Abstract][Full Text] [Related]
19. Silexan in anxiety disorders: Clinical data and pharmacological background.
Kasper S; Müller WE; Volz HP; Möller HJ; Koch E; Dienel A
World J Biol Psychiatry; 2018 Sep; 19(6):412-420. PubMed ID: 28511598
[TBL] [Abstract][Full Text] [Related]
20. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.
Bailer UF; Frank GK; Henry SE; Price JC; Meltzer CC; Weissfeld L; Mathis CA; Drevets WC; Wagner A; Hoge J; Ziolko SK; McConaha CW; Kaye WH
Arch Gen Psychiatry; 2005 Sep; 62(9):1032-41. PubMed ID: 16143735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
